Featured series 
Tag: Pfizer
-
Health
Pills could prove COVID game changer
Harvard specialists say COVID-19 pills may cut hospitalizations and deaths and offer big boost to nations struggling with low vaccination rates.
-
Campus & Community
How Harvard is handling COVID vaccinations
The Gazette spoke with Giang Nguyen, executive director of Harvard University Health Services, about how the University prepared for the arrival of vaccine, where we are now in the process of vaccinating the Harvard community, and why it’s so important for everyone who is eligible to get vaccinated against COVID-19.
-
Work & Economy
COVID vaccine race leaders likely won’t be only ones to reap huge payday
The coronavirus pandemic will likely make some vaccine companies rich, but which companies and how rich relies on the still-murky future of the pandemic, a Harvard health policy expert said.
-
Health
U.S. failed to control pandemic, but vaccination provides ‘chance to get next phase right’
Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.
-
Health
Major step in preventing type 2 diabetes
Researchers at the Broad Institute and Massachusetts General Hospital, both Harvard affiliates, have identified mutations in a gene that can reduce the risk of individuals developing type 2 diabetes. If a drug can be developed that mimics the protective effect of these mutations, it could open up new ways of preventing this devastating disease.
-
Health
Fixing the way we fix the brain
With neurodegenerative diseases affecting millions and having the potential to bankrupt the U.S. health care system, Harvard Medical School, seven pharmaceutical companies, and the Massachusetts state government have formed the Massachusetts Neuroscience Consortium. The goal: to offer new collaborative research models.
